Cancer

Checkmate 7DX

A Study of Nivolumab or Placebo in Combination with Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer - CheckMate 7DX

Trial overview

Disease

Prostate cancer

Topic

Checkmate 7DX

Sponsor

Description

The purpose of this study is to assess the safety and effectiveness of nivolumab with docetaxel in men with advanced castration resistant prostate cancer who have progressed after second-generation hormonal manipulation

Study details

For detailed information on this trial, please click here

Trial status

Actively recruiting

Location

Principle Investigator

Dr Mark Tuthill

MBBS BSc PhD FRCP

Consultant Medical Oncologist

Oxford